𝔖 Bobbio Scriptorium
✦   LIBER   ✦

607 Effectiveness of Oral Valganciclovir Prophylaxis for Cytomegalovirus Infection in Heart Transplant Patients

✍ Scribed by A.O. Doesch; J. Repp; S. Celik; J. Franke; L. Frankenstein; A. Ruhparwar; P. Schnitzler; P. Ehlermann; C. Zugck; T.J. Dengler; H.A. Katus

Book ID
116523435
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
63 KB
Volume
30
Category
Article
ISSN
1557-3117

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au